HIV co-infection with tuberculous and non-tuberculous mycobacteria in western Kenya: Challenges in the diagnosis and management

African Health Sciences

Volumn 12, Issue 3, 2012, Pages 305-311

  Nyamogoba, H D N ^a   Mbuthia, G ^a   Mining, S ^a   Kikuvi, G ^a   Biegon, R ^a   Mpoke, S ^b   Menya, D ^a   Waiyaki, P G ^c  

^a MOI UNIVERSITY   (Kenya)

^b JOMO KENYATTA UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Kenya)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

High prevalence; HIV co infection; TB diagnosis; Tuberculosis

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIVIRAL THERAPY; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHILD; CROSS-SECTIONAL STUDY; DIAGNOSTIC ERROR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; KENYA; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MIXED INFECTION; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM PEREGRINUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRESCHOOL CHILD; PREVALENCE; SEX RATIO; SPUTUM ANALYSIS; TUBERCULOSIS;

HIGH PREVALENCE; HIV CO-INFECTION; TB DIAGNOSIS; TUBERCULOSIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHILD; CHILD, PRESCHOOL; COINFECTION; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; KENYA; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; MYCOBACTERIUM TUBERCULOSIS; NONTUBERCULOUS MYCOBACTERIA; PREVALENCE; QUESTIONNAIRES; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; SPUTUM; TUBERCULOSIS; YOUNG ADULT;

EID: 84872460834     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: 10.4314/ahs.v12i3.9     Document Type: Article

References (38)

1. WHO Report. Global tuberculosis control: Surveillance, Planning, Financing, Communicable Diseases. WHO, Geneva, 2002.
2. UNAIDS. Global Facts and Figures: The global AIDS epidemic. 2009.
3. WHO. Tuberculosis Facts, 2009. www.who.int/tb/publications/2009/tbfactsheet_2009_onepage.pdf
4. Bakare N, Miller V. HIV-TB co-infection: meeting the challenge. Report of the Forum for Collaborative HIV Research and TB/HIV. Working Group of the Stop TB Partnership Symposium and Roundtable discussions on HIV/ TB. July 22-23, 2007, Sydney Australia, report date: November 2, 2007.
5. Nullis-Kapp C. Africa is worst hit by dual epidemic. Bull World Health Organ 2005; 83(3): 165-6.
6. Nunn P, Brindle R, Carpenter L, Odhiambo J, Wasunna K, Newnham R, et al. Cohort-study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6 months) mortality. Am Rev Respir Dis. 1992; 146: 849-54.
7. Daley CL, Small PM, Scheeter GF, Schoolink GK, McAda RA, Jacobs WR, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the Human immunodeficiency virus. An analysis using restriction - fragment -length polymorphism. N. Eng J. Med 1992; 262: 231.
8. Villarino ME, Dooley SW, Geither LJ, Castro K, Snider D. Management of persons exposed to multidrug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep. 1992; 41 (RR-11): 61-71.
9. Mallory KF, Churchyard GJ, Kleinschmidt I, Decock KM, Corbett EL. The Impact of HIV Infection on Recurrence of Tuberculosis in South African Gold Miners. Int J Tuberc Lung Dis 2000; 4(5): 455-62.
10. Wallis RS, Vjecha M, Nelson M, Okwera A, Byekwaso F, Nyole S, Kabengera S, et al. Influence of tuberculosis on human 2-immunodeficiency virus (HIV-1): Enhanced cytokine expression and elevated microglobulin in HIV-1-associated tuberculosis. J Infect Dis 1993; 167:43-8.
11. Ackah AN, Caulibaly D, Digbeu H, Diallo K, Vetter KM, Coulibaly IM, Greenberg AE, et al. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Ivory Coast. Lancet 1995; 354(8950):607-610.
12. Whalen C, Lahart C, Hom D, Lahart C, Simberkoff M, Ellner J. Accelerated course of HIV infection after tuberculosis. Am J Respir Crit Care Med 1995; 151:129-35.
13. Grant DA, Sidile K, Domousa K, Bonard D, Sylla-Koko F, Dosso M., et al. Spectrum of disease among HIV-infected adults hospitalized in a respiratory medicine unit in Abidjan, Cote d'Ivoire. Int J Lung Dis 1998; 2(11): 926-34.
14. WHO. AIDS, Global situation of the HIV/AIDS pandemic. Wkly Epidemiol Rec 1995; 70: 193.
15. Global Health Council. Co-infection. http://72.3.236.96/infectious_diseases/co_infection/
16. Division of Leprosy, tuberculosis and Lung Disease (DLTLD), Ministry of Public Health and Sanitation, Government of Kenya. Annual Report, 2009.
17. Azevedo MJ, Prater GS, Hayes SC. Human immunodeficiency virus and tuberculosis coinfection in Kenya: Environment, Resources and Culture. International Journal of sociology and Anthropology. 2010; 2(4): 55-65.
18. Johnson, JL, Ellner, JJ. Tuberculosis and Atypical Mycobacterial Infections. In: Tropical Infectious Diseases: Principles, Pathogens & Practice, Vol. 1. Guerrrant, R. L., Walker, D. H. and Weller, P. F. eds. Churchill Livingstone, Philadelphia. 1999. Pp. 443-73.
19. Wolinsky E. Mycobacterial diseases other than tuberculosis. Clin Infect Dis. 1992; 15:(1): 1-10.
20. National Leprosy and Tuberculosis Programme (NLTP). (2003), Ministry of Health, Republic of Kenya. Tuberculosis Guidelines.
21. World Health Organization (WHO). Guidelines for the prevention of tuberculosis in healthcare facilities in resource-limited settings. WHO, Geneva. 1999.
22. Ebersole, L. L. Acid-fast stain procedures. In: Isenberg HD, ed. Clinical Micribiology Procedure Handbook. Washington, DC: ASM Press; 1992:3.5.1-3.5.10.
23. Find. MGITTM Procedure Manual for BACTEC TM MGIT 960TM TB System, 2006.
24. Schutz, C., Meinjtjes, G., Almajid, F., Wilkinson, R. J. and Pozniak, A. Clinical management of tuberculosis and HIV-1 co-infection. ERJ 2010; 36 (6): 1460-1481.
25. Division of Leprosy, tuberculosis and Lung Disease (DLTLD), Ministry of Public Health and Sanitation, Government of Kenya. Annual Report, 2007.
26. Division of Leprosy, tuberculosis and Lung Disease (DLTLD), Ministry of Public Health and Sanitation, Government of Kenya. Annual Report, 2008.
27. WHO Report. Global tuberculosis control: Surveillance, Planning, Financing. Geneva, 2007.
28. National institute of child health and human development (NICHD). (2007). http://www.nichd.nih.gov
29. National institute of health (NIH) (2007). http://www.nih.gov
30. National institute of mental health (NIMH). (2007). http://www.nimh.nih.gov
31. World Health Organization. Treatment of tuberculosis. Guidelines for National Programmes. WHO/CDS/TB 2003: 313). Geneva. 2003.
32. American Thoracic Society (ATS). An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. 2007.
33. Buijtels PCAM. Clinical relevance of nontuberculous mycobacteria in Zambia. PhD thesis. 2007
34. World Health Organization. Interim policy on collaborative TB/HIV activities. Geneva. 2005.
35. World Health Organization WHO). Treatment of Tuberculosis: guidelines for national programmes 4th edition, WHO/HTM/TB/2009.420. 2009.
36. Buijtels PCAM, van der Sande MAB, de Graaff CS, Parkinson S, Verbrugh HA, Petit PLC, et al. Nontuberculous mycobacteria, Zambia. Emerg Infect Dis 2009; 15(2): 242-249.
37. Olson ES, Simpson AJH, Norton AJ and Das SS. Not everything acid fast is Mycobacterium tuberculosis: a case report. J Clin Pathol 1998; 51: 535-536.
38. Griffith DE, Aksamit T, Brown-Elliot BA, Catanzaro A, Daley C, Gordin F, et al. ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Diseases Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit Care Med 2007; 175: 367-416.